WMJ Vol 124 Issue 2: Mind the Gap: Analysis of the Timeline of Medical Readiness and Qualitative Review of Discharge Delays

ABSTRACT

Introduction: Efficient discharges lead to decreased length of stay and improved hospital flow. An efficient discharge requires timely recognition of medical readiness for discharge (MRD) and effective preparation. The objective of this study was to better understand pediatric hospital medicine discharges by (1) analyzing the time of MRD and discharge throughout the day, (2) assessing the time from MRD to discharge, and (3) categorizing commonly identified discharge delays.

Methods: A retrospective chart review of pediatric hospital medicine patients with the diagnoses of asthma, “brief resolved unexplained event,” hyperbilirubinemia, or “rule out sepsis neonates” was completed. MRD was determined by reviewing the patient’s chart for completion of diagnosis-specific discharge criteria. MRD was compared to the time of discharge order and discharge. Delayed discharges were reviewed further to identify reasons for the delay.

Results: One hundred discharge events were analyzed – 25 from each of the 4 selected diagnoses. MRD occurred throughout the day (33% morning, 43% afternoon, 14% evening, and 10% night). The median time from MRD to discharge was 1.7 hours (0.5 hours from MRD to discharge order and 0.9 hours from order to discharge), with the longest MRD to discharge time in asthma patients. Forty percent of patients had a delayed discharge, and identified reasons for delays were further categorized.

Conclusions: MRD occurred throughout the day, suggesting the MRD to discharge time may be an informative metric of discharge efficiency. Next steps include developing forward-facing electronic health record alerts noting MRD for improved tracking and real-time communication and targeted interventions to address reasons for discharge delays.

Intended Audience

The intended audience for this continuing education activity is healthcare professionals caring for the people of Wisconsin and beyond.

Learning Objectives

As a result of participating in this journal-based activity, healthcare team members will be able to:

  1. Explain how discharge delays in pediatric hospital medicine affect hospital flow, length of stay, and patient care outcomes.
  2. Summarize findings from a review of 100 pediatric discharge events, including timing of medical readiness for discharge (MRD), median time from MRD to discharge, and common reasons for delays.
  3. Discuss strategies for healthcare teams to reduce discharge delays, including diagnosis-specific readiness pathways, EHR alerts for MRD, and targeted interventions for frequent barriers such as medication coordination and patient/family education.
Course summary
Available credit: 
  • 0.75 AAPA Category 1 CME
  • 0.75 ACPE Contact Hours - Pharmacist
  • 0.75 AMA PRA Category 1 Credit
  • 0.75 ANCC Contact Hours
  • 0.75 University of Wisconsin–Madison Continuing Education Hours
    • 0.75 Approved for AMA PRA Category 1 Credit™
Registration opens: 
05/26/2026
Course expires: 
05/25/2027
Cost:
$0.00
Rating: 
0

FACULTY DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

Name of IndividualIndividual's Role in ActivityFinancial Relationship DisclosureDiscussion of Unlabeled/Unapproved Uses of Drugs/Devices
Marianna Shershneva, MD, PhDAccreditation SpecialistNo relevant relationships with ineligible companies to discloseNo
James Eberhard, MFAAccreditation SpecialistNo relevant relationships with ineligible companies to discloseNo
Madeleine Nowak, BSAuthorNo relevant relationships with ineligible companies to discloseNo
Matthew Bye, MPHAuthorNo relevant relationships with ineligible companies to discloseNo
Amanda Rogers, MDAuthorNo relevant relationships with ineligible companies to discloseNo
Karol Kremens, MDReviewerNo relevant relationships with ineligible companies to discloseNo
Anu TaylorReviewerNo relevant relationships with ineligible companies to discloseNo
Patrick H. Ginn, MDReviewerNo relevant relationships with ineligible companies to discloseNo
Robert Treat, PhDEditorNo relevant relationships with ineligible companies to discloseNo
David Dwyer, PhD, RN, NEBCReviewerNo relevant relationships with ineligible companies to discloseNo
Kevin Wyne, PAC, MPAS, MScReviewerNo relevant relationships with ineligible companies to discloseNo
Jennifer Esch, PharmD, MBA, BCPSReviewerNo relevant relationships with ineligible companies to discloseNo

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.

Discloser List CME Internal Report

Accreditation and Credit Designation Statements

Accreditation Logos
Accreditation Statements
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal.  The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 0.75 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 0.75 ANCC contact hour.  

American Academy of Physician Assistants (AAPA)

The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 03/25/2027. PAs should only claim credit commensurate with the extent of their participation.

 

Accreditation Council for Pharmacy Education (ACPE)

The University of Wisconsin–Madison ICEP designates this knowledge-based activity for 0.75 hours or 0.075 CEUs. Credit can be earned by successfully completing the activity. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

UAN:  

 

Continuing Education Units

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.

Available Credit

  • 0.75 AAPA Category 1 CME
  • 0.75 ACPE Contact Hours - Pharmacist
  • 0.75 AMA PRA Category 1 Credit
  • 0.75 ANCC Contact Hours
  • 0.75 University of Wisconsin–Madison Continuing Education Hours
    • 0.75 Approved for AMA PRA Category 1 Credit™

Cost:
$0.00
Please login or register to take this course.

Accessibility

If you need anything to participate in this program, please contact [email protected].

Required Hardware/software

Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly. 

Free, current version of Adobe Acrobat Reader or other .pdf reader.